Refinement of Peptidomimetics toward MUR-2425: A Brain-Penetrant and Selective Caspase-2 Inhibitor with Enhanced Pharmacokinetics
Authors:
Open Access
- 5 November 2026
- journal article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
Abstract
Caspase-2 (Casp2) has emerged as a promising target for tau-associated neurodegenerative diseases, yet the development of potent, selective, and drug-like inhibitors remains challenging. Here, we report a systematic structure–activity relationship study of 80 novel covalent-reversible peptidomimetic Casp2 inhibitors, revealing key structural features of the Casp2 S2–S3 binding site and discovering (S)-2-methylindoline-2-carboxylic acid (2-Me-Idc) and quinaldic acid (Quin) as versatile and stable P5 scaffolds. One-step conversion of the aldehyde warhead into a nitrile remarkably enhanced selectivity while maintaning potency. The results culminate in MUR-2425 (87, (2-Me-Idc)(hE)VP*D-CN), a nanomolar Casp2 inhibitor (pKi (cpCasp2) = 7.75) with ≥525-fold selectivity over Casp1/3/4/5/6/7/9/10 and 24-fold over Casp8. MUR-2425 prevents the formation of neurotoxic Δtau314 in vitro, exhibits stable ADMET properties across human, rat, and mouse species and proves brain penetrance after subcutaneous injection in CD-1 mice. MUR-2425 is confirmed to engage Casp2 covalently by cocrystallization, supporting its further development for Alzheimer’s disease and related dementias.Keywords
Funding Information
- Deutsche Forschungsgemeinschaft (PO 2563/3-1)
- Deutsche Forschungsgemeinschaft (PO 2563/4-1)
- National Institute on Aging (R01AG062199)
- Fonds der Chemischen Industrie (661688)
- Lucas Brothers Foundation
- Alzheimer Forschung Initiative
This publication has 56 references indexed in Scilit:
- “Real‐world” eligibility for anti‐amyloid treatment in a tertiary memory clinic settingAlzheimer's & Dementia, 2025
- Anti-Amyloid Monoclonal Antibodies for the Treatment of Alzheimer’s DiseaseBioDrugs, 2023
- Characterization of caspase‐2 inhibitors based on specific sites of caspase‐2‐mediated proteolysisArchiv der Pharmazie, 2022
- Old and Novel Functions of Caspase-22017
- The Role of Proteases in Hippocampal Synaptic Plasticity: Putting Together Small Pieces of a Complex PuzzleNeurochemical Research, 2015
- Exploiting differences in caspase-2 and -3 S2 subsites for selectivity: Structure-based design, solid-phase synthesis and in vitro activity of novel substrate-based caspase-2 inhibitorsBioorganic & Medicinal Chemistry, 2011
- A Highly Potent and Selective Caspase 1 Inhibitor that Utilizes a Key 3‐Cyanopropanoic Acid MoietyChemMedChem, 2010
- Post-translational modifications of tau protein in Alzheimer’s diseaseJournal of Neural Transmission, 2004
- Expression, Purification, and Characterization of CaspasesCurrent Protocols in Protein Science, 2002
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973